Role of ETa and ETB receptors in endothelin-1-induced adrenal catecholamine secretion in vivo

American Journal of Physiology

Volumn 272, Issue 4 PART 2, 1997, Pages

  Yamaguchi, Nobuharu ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Anesthetized dogs; BQ 123; BQ 788; Endothelin A antagonist; Endothelin B antagonist

Indexed keywords

EID: 33745370539     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Allcock, G. H., T. D. Warner, and J. R. Vane. Role of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked ratuse of selective antagonists. Br. J. Pharmacol. 116: 2482-2486, 1995.
2. Arai, H., S. Horii, I. Aramori, H. Ohkubo, and S. Nakanishi. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732, 1990.
3. Bax, W. A., and P. R. Saxena. The current endothelin receptor classification: time for reconsideration? Trends Pharmacol. Sci. 15: 379-386, 1994.
4. Belloni, A. S., P. G. Andreis, G. Neri, and G. G. Nussdorfer. Endothelin-1 (ET-1) and cyclosporine-A (CSA) stimulate steroid secretion from rat adrenal cortex-evidence that both ET-1 and CSA secretagogue effects are mediated by the B subtype of ET-1 receptors. Biomed. Res. 16: 287-294, 1995.
5. Boarder, M. R., and D. B. Marriott. Characterization of endothelin-1 stimulation of catecholamine release from adrenal chromaffin cells. J. Cardiovasc. Pharmacol. 13, Suppl. 5: S223-S224, 1989.
6. Boarder, M. R., and D. B. Marriott. Endothelin-1 stimulation of noradrenaline and adrenaline release from adrenal chromaffin cells. Biochem. Pharmacol. 41: 521-526, 1991.
7. Bottig, R. M., and J. R. Vane. Endothelins: potent releasers of prostacyclin and EDRF. Pol. J. Pharmacol. Pharm. 42: 203-218, 1990.
8. Briand, R., S. Foucart, T. Kimura, L. Farlery, N. Yamaguchi, J. Gagné, R. Nadeau, and J. de Champlain. Co-release of neuropeptide Y with catecholamines from the adrenal gland during splanchnic nerve stimulation in the dog. Can. J. Physiol. Pharmacol. 68: 363-369, 1990.
9. Davenport, A. P., R. E. Kuc, J. J. Maguire, and S. P. Harland. ET(A) receptors predominate in the human vasculature and mediate constriction. J. Cardiovasc. Pharmacol. 26, Suppl. 3: S265-S267, 1995.
10. De Nucci, G., R. Thomas, J. P. D'Orléans, E. Antunes, C. Walder, T. D. Warner, and J. R. Vane. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium derived relaxing factor. Proc. Natl. Acad. Sci. USA 85: 9797-9800, 1988.
11. Edwards, R. M., M. Pullen, and P. Nambi. Activation of endothelin ETB receptors increases glomerular cGMP via an L-arginine-dependent pathway. Am. J. Physiol. 263 (Renal Fluid Physiol. 32): F1020-F1025, 1992.
12. Fukami, T., T. Nagase, K. Fujita, T. Hayama, K. Niiyama, T. Mase, S. Nakajima, T. Fukuroda, T. Saeki, M. Nishikibe, M. Ihara, M. Yano, and K. Ishikawa. Structure-activity relationships of cyclic pentapeptide endothelin A receptor antagonists. J. Med. Chem. 38: 4309-4324, 1995.
13. Horn, G. J., W. A. Schutt, and G. M. Rubanyi. Potential mechanisms of endothelin-induced transient decreases in arterial pressure in SHR. In: Endothelium-Derived Contracting Factors, edited by G. M. Rubanyi and P. M. Vanhoute. Basel, Switzerland: Karger, 1990, pp. 98-103.
14. Inoue, A., M. Yanagisawa, S. Kimura, Y. Kasuya, T. Miyauchi, K. Goto, and T. Masaki. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. USA 86: 2863-2867, 1989.
15. Ishikawa, K., M. Ihara, K. Noguchi, T. Mase, N. Mino, T. Saeki, T. Fukuroda, T. Fukami, S. Ozaki, T. Nagase, M. Nishikibe, and M. Yano. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. USA 91: 4892-4896, 1994.
16. Knotek, M., O. Jaksic, R. Selmani, B. Skoric, and H. Banfic. Different endothelin receptor subtypes are involved in phospholipid signalling in the proximal tubule of rat kidney. Pflügers Arch. 432: 165-173, 1996.
17. Koseki, G., M. Imai, Y. Hirata, M. Yanagisawa, and T. Masaki. Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide? Am. J. Physiol. 256 (Regulatory Integratiue Comp. Physiol 25): R858-R866, 1989.
18. Lotersztajn, S. Endothelins. Med. Sci. 9: 1084-1093, 1993.
19. Masaki, T. Endothelins: homeostatic and compensatory actions in the circulatory and endocrine systems. Endocrine Rev. 14:256-268, 1993.
20. Masaki, T., J. R. Vane, and P. M. Vanhoutte. International Union of Pharmacology Nomenclature of endothelin receptors. Pharmacol. Rev. 46: 137-142, 1994.
21. Ohlstein, E. H., S. A. Douglas, D. P. Brooks, D. W. P. Hay, G. Z. Feuerstein, and R. R. Ruffolo, Jr. Functions mediated by peripheral endothelin receptors. In: Endothelin Receptors from the Gene to the Human, edited by R. R. Ruffolo, Jr. Boca Raton, FL: CRC, 1995, p. 109-185.
22. Ohlstein, E. H., P. Nambi, and R. R. Ruffolo, Jr. Endothelin receptor subclassification. In: Endothelin Receptors from the Gene to the Human, edited by R. R. Ruffolo, Jr. Boca Raton, FL: CRC, 1995, p. 15-36.
23. Rubanyi, G. M., and M. A. Polokoff. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev.. 46:325-415, 1994.
24. Sakurai, T., M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, K. Goto, and T. Masaki. Cloning of cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735, 1990.
25. Thiemermann, C., P. S. Lidbury, G. R. Thomas, and J. R. Vane. Endothelin 1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit. J. Cardiovasc. Pharmacol. 13, Suppl. 5: S138-S141, 1989.
26. Wallenstein, S., C. L. Zucker, and J. Fleiss. Some statistical methods useful in circulation research. Circ. Res. 47: 1-9, 1980.
27. Yamaguchi, N. Inhibition by nifedipine of endothelin-induced adrenal catecholamine secretion in anesthetized dogs. Can. J. Physiol. Pharmacol. 71: 301-305, 1993.
28. Yamaguchi, N. In vivo evidence for adrenal catecholamine release mediated by non-nicotinic mechanism: local medullary effect of VIP. Am. J. Physiol. 265 (Regulatory Integrative Comp. Physiol. 34): R766-R771, 1993.
29. 2+ channels in noncholinergic adrenal catecholamine secretion by endothelin-1 in vivo. Am. J. Physiol. 269 (Regulatory Integrative Comp. Physiol. 38): R287-R293, 1995.
30. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.